Common presence of non-transferrin-bound iron among patients with type 2 diabetes

Diabetes Care

Volumn 29, Issue 5, 2006, Pages 1090-1095

  Lee, Duk Hee ^a   Ding, Yong Liu ^b   Jacobs Jr , David R ^c,d   Shin, Hai Rim ^e   Song, Kyungeun ^a   Lee, In Kyu ^a   Kim, Bowan ^a   Hider, Robert C ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

EID: 33746383083     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc05-2471     Document Type: Article

References (22)

1. Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr: Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 80:1194-1200, 2004
2. Will JC, Byers T: Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 54:193-202, 1996
3. Will JC, Ford ES, Bowman BA: Serum vitamin C concentrations and diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nut 70:49-52, 1999
4. Halliwell B: Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res 25:439-454, 1996
5. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J: Vitamin C exhibits pro-oxidant properties. Nature 392:559, 1998
6. Carr A, Frei B: Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13:1007-1024, 1999
7. Ponka P, Beaumont C, Richardson DR: Function and regulation of transferrin and ferritin. Semin Hematol 35:35-54, 1998
8. Batey RG, Lai Chung Fong P, Shamir S, Sherlock S: A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci 25:340-346, 1980
9. Breuer W, Hershko C, Cabantchik ZI: The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23:185-192, 2000
10. De Feo TM, Fargion S, Duca L, Cesana BM, Boncinelli L, Lozza P, Cappellini MD, Fiorelli G: Non-transferrin-bound iron in alcohol abusers. Alcohol Clin Exp Res 25:1494-1499, 2001
11. de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJ: Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30:248-251, 2000
12. Fernandez-Real JM, Lopez-Bermejo A, Ricart W: Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002
13. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H: Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581-587, 2003
14. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC: Quantification of nontransferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 273:212-220, 1999
15. Le Lan C, Loreal O, Cohen T, Ropert M, Glickstein H, Laine F, Pouchard M, Deugnier Y, Le Treut A, Breuer W, Cabantchik ZI, Brissot P: Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood 105:4527-4531, 2005
16. Lee DH, Jacobs DR Jr: Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 62:442-445, 2004
17. Sulieman M, Asleh R, Cabantchik ZI, Breuer W, Aronson D, Suleiman A, Miller-Lotan R, Hammerman H, Levy AP: Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes. Diabetes Care 27:2730-2732, 2004
18. Scheiber-Mojdehkar B, Lutzky B, Schaufler R, Sturm B, Goldenberg H: Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. J Am Soc Nephrol 15:1648-1655, 2004
19. Driss F, Vrtovsnik F, Katsahian S, Michel C, Baron G, Kolta A, Sedrati N, Mentre F, Mignon F, Cabantchik I, Grandchamp B: Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 99:c63-c67, 2005
20. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 25:2249-2255, 2002
21. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and β-cell function. Diabetes 51:1000-1004, 2002
22. Jacobs EM, Hendriks JC, van Tits BL, Evans PJ, Breuer W, Liu DY, Jansen EH, Jauhiainen K, Sturm B, Porter JB, Scheiber-Mojdehkar B, von Bonsdorff L, Cabantchik ZI, Hider RC, Swinkels DW: Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 341:241-250, 2005